eutrophil to Lymphocyte Ratio as A Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy in HRH Princess Maha Chakri Sirindhorn Medical Center
- Conditions
- eutrophil to lypmphocte ratio in Non-arteritic Anterior Ischemic Optic Neuropathyneutrophil to lymphocyte ratio, Non-arteritic Anterior Ischemic Optic Neuropathy
- Registration Number
- TCTR20210506003
- Lead Sponsor
- HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University
- Brief Summary
The neutrophil lymphocyte ratio could be one of the marker that increase in NAION patients. The advantages of the neutrophil lymphocyte ratio were the low cost and the high availability of the resource. Moreover it could be used as the predictive factor for the visual outcomes of the NAION patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 16
1. Acute painless visual loss
2. Presence of relative afferent pupillary defect
3. Visual field defect which is compatible with disease
4. Optic nerve head change that is consistent with disease
5. No other abnormal ophthalmic findings that can mimic other ophthalmic disease
1. Subjects with underlying disease effected a blood test result e.g. inflammatory diseases, leukemia, thrombocytosis, and Multiple myeloma
2. History of smoking and alcohol drinking
3. Retinal diseases e.g. diabetic retinopathy, retinal vein occlusion and hypertensive retinopathy
4. Glaucoma diseases
5. Other Neuro-opthalmic diseases 6.the patient who received any kind of treatment for NAIO
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method neutrophil lymphocyte ratio at first examination in NAION group and at pre operative evaluation day in the other two groups complete blood count
- Secondary Outcome Measures
Name Time Method visual acuity (VA) First time examination, 3 months follow up snellen chart